Strain and schedule-dependent differences in the acquisition, maintenance and extinction of intravenous cannabinoid self-administration in rats - PubMed (original) (raw)
Comparative Study
Strain and schedule-dependent differences in the acquisition, maintenance and extinction of intravenous cannabinoid self-administration in rats
Serena Deiana et al. Neuropharmacology. 2007 Feb.
Abstract
Cannabinoids have been reported to sustain self-administration in laboratory animals; however, genetic differences and environmental factors critical in the initiation and retention of such behaviour are yet to be defined. This study investigated the acquisition, maintenance and extinction of self-administration of the cannabinoid CB1 receptor agonist WIN 55,212-2 (6.25-25 microg/kg/inf) in Long Evans, Lister Hooded and Sprague-Dawley rats under a continuous schedule of reinforcement and two different response-like operanda, nose-poking and lever-pressing. Results showed that Long Evans and Lister Hooded, but not Sprague Dawley, rats acquired and retained stable cannabinoid self-administration behaviour under both modus operandi, as defined by significant differences between responding in the active versus the inactive hole/lever. In rats developing firm self-administration, substitution of saline for WIN 55,212-2 extinguished the responding, supporting the notion that cannabinoids may serve as a positive reinforcer in laboratory animals. Nevertheless, significant differences among strains and responding modalities were observed in the percentage of acquisition, amount of drug intake during maintenance and timing of extinction. In addition, no significant strain differences were found in motor response to WIN 55,212-2 (0.3 and 3.0 mg/kg), thus excluding that strain differences observed during cannabinoid self-administration could be related to different cannabinoid-induced locomotor effects.
Similar articles
- Cannabinoid self-administration in rats: sex differences and the influence of ovarian function.
Fattore L, Spano MS, Altea S, Angius F, Fadda P, Fratta W. Fattore L, et al. Br J Pharmacol. 2007 Nov;152(5):795-804. doi: 10.1038/sj.bjp.0707465. Epub 2007 Sep 24. Br J Pharmacol. 2007. PMID: 17891164 Free PMC article. - Intravenous self-administration of the cannabinoid CB1 receptor agonist WIN 55,212-2 in rats.
Fattore L, Cossu G, Martellotta CM, Fratta W. Fattore L, et al. Psychopharmacology (Berl). 2001 Aug;156(4):410-6. doi: 10.1007/s002130100734. Psychopharmacology (Berl). 2001. PMID: 11498718 - Cannabinoid receptor stimulation increases motivation for nicotine and nicotine seeking.
Gamaleddin I, Wertheim C, Zhu AZ, Coen KM, Vemuri K, Makryannis A, Goldberg SR, Le Foll B. Gamaleddin I, et al. Addict Biol. 2012 Jan;17(1):47-61. doi: 10.1111/j.1369-1600.2011.00314.x. Epub 2011 Apr 26. Addict Biol. 2012. PMID: 21521420 - Monitoring extracellular dopamine in the rat nucleus accumbens shell and core during acquisition and maintenance of intravenous WIN 55,212-2 self-administration.
Lecca D, Cacciapaglia F, Valentini V, Di Chiara G. Lecca D, et al. Psychopharmacology (Berl). 2006 Sep;188(1):63-74. doi: 10.1007/s00213-006-0475-3. Epub 2006 Jul 19. Psychopharmacology (Berl). 2006. PMID: 16850116 - Evaluation of WIN 55,212-2 self-administration in rats as a potential cannabinoid abuse liability model.
Lefever TW, Marusich JA, Antonazzo KR, Wiley JL. Lefever TW, et al. Pharmacol Biochem Behav. 2014 Mar;118:30-5. doi: 10.1016/j.pbb.2014.01.002. Epub 2014 Jan 9. Pharmacol Biochem Behav. 2014. PMID: 24412835 Free PMC article.
Cited by
- URB597 induces subtle changes to aggression in adult Lister Hooded rats.
Warren WG, Hale E, Papagianni EP, Cassaday HJ, Stevenson CW, Stubbendorff C. Warren WG, et al. Front Psychiatry. 2022 Aug 12;13:885146. doi: 10.3389/fpsyt.2022.885146. eCollection 2022. Front Psychiatry. 2022. PMID: 36032247 Free PMC article. - Cannabinoid-mediated diversity of antinociceptive efficacy of parecoxib in Wistar and Sprague Dawley rats in the chronic constriction injury model of neuropathic pain.
Becker A, Geisslinger G, Murín R, Grecksch G, Höllt V, Zimmer A, Schröder H. Becker A, et al. Naunyn Schmiedebergs Arch Pharmacol. 2013 May;386(5):369-82. doi: 10.1007/s00210-013-0839-2. Epub 2013 Feb 1. Naunyn Schmiedebergs Arch Pharmacol. 2013. PMID: 23371449 - Cannabinoid-induced conditioned place preference in the spontaneously hypertensive rat-an animal model of attention deficit hyperactivity disorder.
Pandolfo P, Vendruscolo LF, Sordi R, Takahashi RN. Pandolfo P, et al. Psychopharmacology (Berl). 2009 Aug;205(2):319-26. doi: 10.1007/s00213-009-1542-3. Epub 2009 May 1. Psychopharmacology (Berl). 2009. PMID: 19407992 - Behavioural and neurochemical assessment of salvinorin A abuse potential in the rat.
Serra V, Fattore L, Scherma M, Collu R, Spano MS, Fratta W, Fadda P. Serra V, et al. Psychopharmacology (Berl). 2015 Jan;232(1):91-100. doi: 10.1007/s00213-014-3641-z. Epub 2014 Jun 13. Psychopharmacology (Berl). 2015. PMID: 24923984 - Endocannabinoid system involvement in brain reward processes related to drug abuse.
Solinas M, Yasar S, Goldberg SR. Solinas M, et al. Pharmacol Res. 2007 Nov;56(5):393-405. doi: 10.1016/j.phrs.2007.09.005. Epub 2007 Sep 8. Pharmacol Res. 2007. PMID: 17936009 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous